THIS NOVEL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain cancer known for its fast growth and unresponsiveness to standard treatments. Research are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for GBM treatment. LCA168 is a protein that is overexpressed in GBM cells compared to n